Published on
October 18, 2016
- 23:27 GMT
U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell(R) in Life-Threatening Injuries
NORTHRIDGE, CA and PERTH, AUSTRALIA and LONDON, UNITED KINGDOM--(Marketwired - Oct 18, 2016) - Up to 48 patients can now be treated at 15 US burns centers Increased use of ReCell® device by US surgeons under the Compassionate Use dispensations Latest FDA …
Distribution channels:
Healthcare & Pharmaceuticals Industry
